Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Qiagen N.V.
(NY:
QGEN
)
46.43
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Qiagen N.V.
< Previous
1
2
3
Next >
QIAGEN to Enter the DAX – Germany’s Leading Stock Market Index
September 03, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to Date
August 23, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR Technology
August 10, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements
August 09, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
August 06, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reports Full Results for Q2 and H1 2021
July 29, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 Results
July 12, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
July 12, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections
July 08, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments
July 07, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Forms Strategic Alliance With Sysmex Corporation for Global Cancer Companion Diagnostics Development and Commercialization Using NGS and Plasma-Safe-SeqS Technology
July 01, 2021
From
QIAGEN N.V.
Via
Business Wire
Verogen Partners with QIAGEN to Deliver Innovative Solutions for Human Identification Laboratories
June 29, 2021
From
Verogen
Via
Business Wire
QIAGEN Partners with Verogen to Offer Broadest Portfolio for Human Identification, Including Next Generation Sequencing Solutions
June 29, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments
June 21, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer
May 28, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Partners With Mirati Therapeutics Inc. to Develop KRASG12C Companion Diagnostic for Non-Small Cell Lung Cancer (NSCLC)
May 25, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Announces Creation of Scientific Advisory Board and Agenda for Annual General Meeting in June 2021
May 17, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies
May 12, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Exceeds Outlook in First Quarter 2021 Results, Reaffirms Sales Growth and Profitability Outlook for Full-Year 2021
May 03, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Announces EZ2 Connect Instrument Line for Automated Sample Processing in Research, Forensics and Diagnostics
April 29, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early diagnosis of Lyme Borreliosis
April 21, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
April 20, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to Report First Quarter 2021 Results
April 20, 2021
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance
April 06, 2021
From
QIAGEN N.V.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.